(Q45884689)

17 December 2017

title

The emerging utility of animal models of chronic neurodegenerative diseases (English)

1 reference

17 December 2017

1 reference

Kahle PJ

1

1 reference

17 December 2017

Haass C

series ordinal

2

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

17 December 2017

Expert Opinion on Therapeutic Targets

published in

1 reference

17 December 2017

volume

5

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

125-132

1 reference

17 December 2017

Worldwide prevalence and incidence of dementia

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

The surgical treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Amyloid diseases: abnormal protein aggregation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Late-onset neurodegenerative diseases--the role of protein insolubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Alzheimer's disease: genetic studies and transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Single and multiple transgenic mice as models for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Assessment of normal and mutant human presenilin function in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Presenilin is required for activity and nuclear access of Notch in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Translating cell biology into therapeutic advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Tau filament formation in transgenic mice expressing P301L tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Transgenic models of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Genetic neurodegenerative diseases: the human illness and transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.1.125

21 January 2018

Identifiers

DOI

10.1517/14728222.5.1.125

1 reference

17 December 2017

1 reference

17 December 2017